Allen Mooney & Barnes Investment Advisors LLC Bristol Myers Squibb CO Transaction History

Allen Mooney & Barnes Investment Advisors LLC

$587 Billion
Q3 2024

A detailed history of Allen Mooney & Barnes Investment Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Allen Mooney & Barnes Investment Advisors LLC holds 36,100 shares of BMY stock, worth $2.12 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

36,100

Previous 36,299 0.55%

Holding current value

$2.12 Million

Previous $1.51 Billion 23.9%

% of portfolio

0.32%

Previous 0.27%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$39.66 - $51.75 $7,892 - $10,298	-199 Reduced 0.55%	36,100 $1.87 Billion
Q2 2024 Jul 11, 2024	BUY	$40.25 - $52.99 $4,709 - $6,199	117 Added 0.32%	36,299 $1.51 Billion
Q1 2024 Apr 12, 2024	SELL	$47.98 - $54.4 $59,927 - $67,945	-1,249 Reduced 3.34%	36,182 $1.78 Billion
Q4 2023 Jan 22, 2024	BUY	$48.48 - $57.85 $25,985 - $31,007	536 Added 1.45%	37,431 $1.92 Billion
Q3 2023 Nov 21, 2023	BUY	$57.89 - $64.73 $2.14 Million - $2.39 Million	36,895 New	36,895 $2.14 Billion
Q2 2023 May 23, 2024	BUY	$63.71 - $70.74 $15,991 - $17,755	251 Added 0.68%	37,229 $2.38 Billion
Q1 2023 May 23, 2024	SELL	$65.71 - $74.53 $100,733 - $114,254	-1,533 Reduced 3.98%	36,978 $2.56 Billion
Q4 2022 May 23, 2024	BUY	$68.48 - $81.09 $159,489 - $188,858	2,329 Added 6.44%	38,511 $2.77 Billion
Q3 2022 May 23, 2024	SELL	$0.13 - $76.84 $102 - $60,473	-787 Reduced 1.89%	40,953 $2.91 Billion
Q2 2022 May 23, 2024	SELL	$72.62 - $79.98 $48,728 - $53,666	-671 Reduced 1.58%	41,740 $3.21 Billion
Q1 2022 May 23, 2024	BUY	$61.48 - $73.72 $382,958 - $459,201	6,229 Added 17.22%	42,411 $3.1 Billion

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allen Mooney & Barnes Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allen Mooney & Barnes Investment Advisors LLC with notifications on news.

Account

Allen Mooney & Barnes Investment Advisors LLC Bristol Myers Squibb CO Transaction History